台股 » 個股 » 醣聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

醣聯

(4168)
  • 股價
    18.00
  • 漲跌
    ▲0.15
  • 漲幅
    +0.84%
  • 成交量
    47
  • 產業
    上櫃 生技醫療類股
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
醣聯 (4168)籌碼相關-富邦-建國 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/0805/101517.52022.52527.5Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

富邦-建國 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/10117.2000.0017.3011440.69%
2025/04/09016.7500.0015.7501320.00%
2025/04/081017.5000.0017.50101198.35%
2025/04/07019.4500.0019.4001130.00%
2025/03/31321.2800.0020.7531182.54%
2025/03/26024.5000.0023.8501120.01%
2025/03/25423.8500.0023.8541183.38%
2025/03/19024.4500.0024.0001320.00%
2025/03/18024.1500.0024.1001320.00%
2025/03/17024.3500.0024.0001330.00%
2025/03/11424.55124.3524.5031352.22%
2025/03/05024.3000.0024.1501350.00%
2025/02/24024.5000.0024.5001350.00%
2025/02/19025.1000.0024.2001350.00%
2025/02/07025.4500.0024.7501440.00%
2025/02/05124.1500.0024.3011470.68%
2025/01/17025.0000.0023.9001640.00%
2025/01/13124.0000.0023.7011630.61%
2025/01/065024.8200.0024.605016230.68%
2025/01/035025.0000.0024.655016430.38%
2025/01/0200.00025.0525.0501660.00%
2024/12/26025.9500.0025.9501670.00%
2024/12/2000.00125.5525.55-1162-0.61%
2024/11/1800.00124.7524.70-1182-0.55%
2024/11/01126.1000.0026.1512230.45%
2024/10/3000.00126.2526.25-1226-0.44%
2024/10/2900.00226.2526.50-2233-0.86%
2024/10/14325.6000.0025.5533490.86%
2024/09/1300.001425.4925.50-14728-1.92%
2024/09/11125.6500.0025.5017310.14%
2024/09/0400.00125.7525.75-1751-0.13%
2024/08/13125.5000.0025.7518820.11%
2024/08/05125.40225.4025.15-1859-0.12%
2024/08/02127.5500.0027.2018490.12%
2024/07/31227.9000.0027.6028400.24%
2024/07/1700.001.130.8130.90-1.1759-0.15%
2024/07/16530.48130.3030.1047480.53%
2024/07/15230.83530.9030.50-3744-0.40%
2024/07/1100.00529.9029.50-5719-0.69%
2024/07/09129.95130.1030.3507130.00%
2024/07/0800.00531.7031.05-5708-0.71%
2024/07/051530.80330.8331.00126921.73%
2024/07/0300.004229.3929.65-42720-5.83%
2024/07/024429.61329.7829.45417145.74%
2024/06/28130.2000.0030.1016790.15%
2024/06/27230.8017230.7530.00-170656-25.88% 大賣/鉅額交易
2024/06/262928.87229.6030.65276004.50%
2024/06/2514529.1600.0029.0014555326.21% 大買/鉅額交易
2024/06/2400.00227.4828.75-2496-0.40%
2024/06/21126.9500.0026.9514590.22%
2024/06/2000.00127.3026.55-1452-0.22%
2024/06/17126.9500.0026.8014460.22%
2024/06/13226.6500.0026.5524430.45%
2024/06/12126.9500.0026.8514410.23%
2024/06/06527.0800.0026.9554301.16%
2024/06/05127.60128.0527.6504240.00%
2024/06/04127.30127.4527.5004300.00%
2024/06/0310.428.32328.7827.757.44431.67%
2024/05/31228.10328.1528.20-1374-0.27%
2024/05/29126.3000.0026.2513310.30%
2024/05/27025.7000.0025.6003250.00%
2024/05/2400.00224.8024.90-2322-0.62%
2024/05/1500.00225.1825.15-2323-0.62%
醣聯生物相似藥正式進入臨床三期 2026年Q2解盲Anue鉅亨-2024/12/17
醣聯完成生物相似藥一期試驗 Q4啟動三期臨床Anue鉅亨-2024/08/19
醣聯 相關文章
醣聯 相關影音